Blood test could predict lupus flares
NCT ID NCT00920114
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study aims to develop a more objective way to measure lupus disease activity using a blood test that analyzes gene activity. Researchers will compare this gene-based score with standard clinical assessments in 80 lupus patients. The goal is to create a non-invasive tool to better track and forecast the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to more accurately track lupus activity and forecast flares.
- What could go wrong
- This is a small, observational study focused on developing a measurement tool, not a treatment. The gene-based score may not prove reliable in larger, diverse groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assistance Publique-Hopitaux de Marseille
Marseille, France